
Cardichem 6.25mg Tablet
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Carvedilol (6.25mg)
Overview Cardichem 6.25mg Tablet
Cardiovasc 6.25mg tablets manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving cardiac blood flow. Reduced blood pressure mitigates stroke and myocardial infarction risk. Administer Cardiovasc 6.25mg with meals, following your physician's prescribed dosage and regimen. Consistent use is crucial, even with symptom improvement or controlled blood pressure. Discontinue only under medical supervision to avoid potential complications. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your doctor), enhance treatment efficacy. While generally well-tolerated, potential side effects include vertigo, cephalgia, dyspnea, and fatigue. Report persistent or bothersome side effects to your doctor. Prior to commencing therapy, disclose any pre-existing cardiac or renal conditions, and pregnant or lactating individuals should seek medical counsel before use.
Uses of Cardichem 6.25mg Tablet
Managing elevated blood pressure | Addressing angina pectoris | Cardiac insufficiency management
Major Benefits of Cardichem 6.25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Cardichem 6.25mg Tablet should be administered with a meal.
Common Side effects of Cardichem 6.25mg Tablet:
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Cardichem 6.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 6.25mg Cardichem tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.
How Cardichem 6.25mg Tablet works:
Cardichem 6.25mg tablets combine alpha and beta-blocking properties. This dual action reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Cardichem 6.25mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Cardichem 6.25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of the 6.25mg Cardichem tablet while breastfeeding is likely safe. Available human data indicate minimal infant risk associated with this medication.
DrivingUNSAFE
Taking a 6.25mg Cardichem tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Cardichem 6.25mg tablets are considered safe, and no dosage modification is typically necessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised. Routine blood pressure monitoring is suggested to guide any potential dose adjustments.
LiverCAUTION
Patients with liver impairment should use Cardichem 6.25mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Cardichem 6.25mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Cardichem 6.25mg Tablet :
Should you forget to take a Cardichem 6.25mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cardichem 6.25mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Carbazole-based compound and a propanol derivative |
| Potential for Dependence | None. |
| Treatment Category | HEART |
| Mechanism of Action | Combined alpha and beta adrenergic receptor antagonist |
